Tvardi Therapeutics Inc. Com
13F holders, Q4 2025 (December 31)3holders −5
1new positions
6sold out
$4.30avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Tvardi Therapeutics Inc. Com in their 13F filings, down 5 from Q3 2025. 1 opened new positions and 6 sold out. The largest holders were Fortitude Family Office, LLC ($546), Farther Finance Advisors, LLC ($13) and Sound Income Strategies, LLC ($9).
- Company
- Tvardi Therapeutics Inc. Com
- CUSIP
- 140755208
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $546 |
| Exits | 6 | $863K |
All 13F filers, Q3 2025 → Q4 2025: 127 shares bought and 22,160 shares sold, net −22,033 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Fortitude Family Office, LLC | 0.00% | New | 127 | $546 |
| Farther Finance Advisors, LLC | 0.00% | No change | 3 | $13 |
| Sound Income Strategies, LLC | 0.00% | No change | 2 | $9 |
"% of holder's portfolio" is TVARDI THERAPEUTICS INC COM's weight in each manager's 13F, not the share of Tvardi Therapeutics Inc. Com the manager owns.